Found 7 matching trials
A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).
PHASE1This single center, multiple ascending dose study will assess the safety, t...
Location
Multiple Locations
A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises
PHASE3This Phase 3 study will assess the safety and efficacy of a single dose of ...
Location
Strada Patient Care Center
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
PHASE2This randomized double-blind, placebo-controlled study will evaluate the ef...
Location
Multiple Locations
A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises
PHASE3This Phase 3 study will assess the safety and efficacy of inclacumab, a P-s...
Location
University of South Alabama Children's and Women's Hospital
A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention
PHASE2This randomized, double-blind, placebo-controlled study will evaluate the e...
Location
Multiple Locations
A Study of Single Dose Inclacumab in Japanese Healthy Volunteers Compared to Caucasian Healthy Volunteers
PHASE1This open-label, parallel group study will evaluate the safety, tolerabilit...
Location
Multiple Locations
A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease
PHASE3This study is an open-label study to evaluate the safety of long-term admin...
Location
Strada Patient Care Center, Pediatric Hematology